Advertisement

Criteria for Diagnosing Early Pregnancy Failure

October 9, 2013

Criteria for Diagnosing Early Pregnancy Failure

  1. Andrew M. Kaunitz MD

New consensus-based guidance allows better determination of location and viability of pregnancy.

  1. Andrew M. Kaunitz MD

Transvaginal ultrasound (TVUS) and serial measurement of serum human chorionic gonadotropin (hCG) have transformed the assessment of pregnant women with early pain and/or bleeding or with other risk factors for ectopic pregnancy (EP) or nonviable intrauterine pregnancy (IUP). With widespread use of these diagnostic modalities, clinicians in obstetrics and gynecology, radiology, emergency medicine, and primary care increasingly encounter early pregnancies of uncertain viability and unknown location — but interpreting the test results to determine appropriate interventions remains challenging. Accordingly, experts in radiology and obstetrics and gynecology have developed a consensus statement from the Society of Radiologists in Ultrasound based on current published data.

The panel states that definitive pregnancy failure can be diagnosed in a woman with an IUP of uncertain viability when TVUS reveals any of the following:

  • Embryonic crown-rump length ≥7 mm and no heartbeat.

  • Mean gestational sac diameter ≥25 mm and no embryo present.

  • No embryo with heartbeat ≥2 weeks after TVUS showed a gestational sac without a yolk sac.

  • No embryo with heartbeat ≥11 days after TVUS showed a gestational sac with a yolk sac.

For evaluation and management of a woman with pregnancy of unknown location when TVUS reveals no intrauterine fluid and no obvious adnexal abnormalities:

  • A single hCG assessment, regardless of level, does not reliably determine a pregnancy's location or viability (this is because hCG levels in women with nonviable IUPs, viable IUPs, and EPs overlap substantially).

  • A single hCG level <3000 mIU/mL should not elicit treatment for presumed EP.

  • A single hCG ≥3000 mIU/mL indicates that viable IUP is possible but unlikely. At least one additional hCG level should be measured before initiating treatment for EP.

For pregnant women in whom TVUS has not been performed:

  • Clinicians should recognize that hCG levels in women with EP are highly variable (but often <1000 mIU/mL), and that hCG level does not predict probability of EP rupture. For high clinical suspicion of EP, TVUS should be performed even if hCG level is low.

Comment

Incorrectly diagnosing an early pregnancy of uncertain viability or location has led some clinicians to prescribe methotrexate for suspected ectopic pregnancy in women later found to have viable intrauterine pregnancies. The authors emphasize that, in hemodynamically stable women, the risk associated with collecting additional data for several more days is limited and will likely allow definitive diagnosis of pregnancy location and viability using the criteria in these guidelines.

  • Disclosures for Andrew M. Kaunitz MD at time of publication Consultant / Advisory board Agile; Bayer; Merck Equity Vertex Royalties UpToDate Grant / research support Agile; Bayer; Endoceutics; Medical Diagnostic Laboratories; Noven; Teva Editorial boards Contraception; MedScape; Menopause; OBG Management Leadership positions in professional societies North American Menopause Society (Board of Trustees)

Citation(s):

Reader Comments (5)

Ade AGBOOLA . MD, FRCSC Physician, Obstetrics/Gynecology

This is a fantastic guideline . However, how does this apply in circumstances where the patient wants methotrexate irrespective of viability or location of the pregnancy?

KAY JACKSON Other Healthcare Professional, Franciscan Medical Group

Does progesterone level play a part here?

Mary Bennett

Regarding the above comment, what would be the point of prescribing methotrexate for a suspected ectopic pregnancy? Wouldn't that carry the risk of unintentionally causing an abortion?
Remember...First do no harm.

Dr. V Kantariya MD Physician, Family Medicine/General Practice

Early Diagnosis of Pregnancy Failure is essential!
First, DO NO HARM!!!

Ruth A Petrucha, MD Physician, Obstetrics/Gynecology, Kaiser Permanente

I like the concise format

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement